Jose Diaz
About Jose Diaz
Jose Diaz is the WW HEOR Lead for HTA Strategy & Affordability at Bristol Myers Squibb in London, with extensive experience in health economics, outcomes research, and clinical practice.
Current Title and Role at Bristol Myers Squibb
Jose Diaz is currently serving as the WW HEOR Lead - HTA Strategy & Affordability at Bristol Myers Squibb in London, England, United Kingdom. His role involves leading health economics and outcomes research and overseeing strategic measures to improve health technology assessment (HTA) and affordability. This position places him at the forefront of ensuring that medications remain accessible, offering significant contributions to the processes related to market access and reimbursement strategies.
Professional Experience at Bristol Myers Squibb
Jose Diaz has held multiple senior roles at Bristol Myers Squibb. From 2017 to 2020, he was the Group Director for Japan & Intercontinental Region in WW HEOR Markets. Prior to that, he served as the Japan & Intercontinental Lead for Worldwide Health Economics & Outcomes Research Markets from 2016 to 2017. His responsibilities in these roles included developing health outcomes strategies and guiding regional health economics research initiatives, solidifying his expertise in global health economics.
Previous Roles in Pharmaceutical Companies
Jose Diaz has a rich history of positions in top pharmaceutical companies prior to his tenure at Bristol Myers Squibb. He worked at Novartis as the Senior Director - Value Evidence Lead (Oncology) in 2015. At GlaxoSmithKline, he served in various capacities, including Senior Director - Value Evidence Leader - Oncology (2014-2015), Global Health Outcomes Director - Oncology (2011-2014), Programme Leader Oncology - Solid Tumors (2009-2011), and Health Outcomes Executive (2008-2009). His work focused on value evidence generation, health outcomes strategies, and oncology program leadership.
Academic and Research Background
Jose Diaz has an extensive academic and research background, contributing to his comprehensive expertise in health economics and policy. He was a NICE Clinical Guidelines - Health Services Research Fellow at the National Collaborating Centre for Chronic Conditions from 2006 to 2008. He also served as a Senior Researcher for the Pharmaceutical Research Policy Project (Neglected Diseases) at The London School of Economics and Political Science (LSE) from 2004 to 2006. His research has significantly impacted pharmaceutical policy and healthcare guidelines.
Educational Qualifications
Jose Diaz holds multiple advanced degrees. He earned an MSc in Health Economics Policy and Management from The London School of Economics and Political Science (LSE) from 2009 to 2011. He also completed an MSc in Social Policy and Planning in Developing Countries at LSE from 2003 to 2004. He achieved his MB BS in Medicine from the Universidad Nacional de Colombia from 1994 to 1999. These academic credentials have equipped him with a robust foundation in healthcare, economics, and social policy.